Novo Nordisk

Novo Nordisk

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

How Novo Nordisk misread the US market for its weight loss sensation

Novo has enjoyed a tremendous windfall of $46 billion in net profit since mid-2021, when Wegovy became the first highly effective obesity treatment approved in the United States

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

Novo's trial of weight-loss drug shows improvement in fatty liver disease

Headquarter of  Novo Nordisk, a leading global healthcare company operating in the Human insulin market. Photo: Collected

Weight-loss drug forecasts jump to $150 billion as supply grows

Novo Nordisk launches once-a-week diabetes drug

Novo Nordisk launches once-a-week diabetes drug

Winnie Estrup Petersen, Ambassador, The Royal Embassy of Denmark in Bangladesh, Dr. Mihail Briciu, Managing Director of Novo Nordisk Bangladesh and Professor Dr. AK Azad Khan, President of Diabetic Association of Bangladesh (BADAS), along with others attend at the launching ceremony of world’s fastest acting insulin at a hotel in the capital on Thursday.

Novo Nordisk introduces world’s fastest acting insulin

Novo Nordisk Bangladesh plants 1,000 trees to support environment

Novo Nordisk Bangladesh plants 1,000 trees to support environment